InsidersTradesSigma
Follow the KALBE FARMA Tbk, PT stock price and the full management transaction log of the company, a listed equity based in Indonesia. Shares trade on the ID market, under the oversight of OJK / IDX. Market capitalisation: €36,651.6bn. The latest transaction was reported on 24 August 2026 (Purchase). Among the most active insiders: FERDINAND ARYANTO. Every trade is openly available.
Analysts rate KALBE FARMA Tbk, PT Strong Buy (bullish), based on 17 analysts. Average price target: IDR 1,175.29.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
KALBE FARMA Tbk, PT is an Indonesian pharmaceutical company specializing in the production of medicines, nutritional products, and health products. It is listed on the Indonesia Stock Exchange (XIDX).